These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2788548)

  • 1. Oxalate retention in chronic renal failure: tubular vs glomerular diseases.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Clin Nephrol; 1989 Aug; 32(2):87-95. PubMed ID: 2788548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis.
    Tomson CR; Channon SM; Ward MK; Laker MF
    Nephrol Dial Transplant; 1989; 4(9):792-9. PubMed ID: 2516611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria.
    Elgstoen KB; Johnsen LF; Woldseth B; Morkrid L; Hartmann A
    Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD).
    Yamauchi A; Fujii M; Shirai D; Mikami H; Okada A; Imai E; Ando A; Orita Y; Kamada T
    Clin Nephrol; 1986 Apr; 25(4):181-5. PubMed ID: 3698351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
    J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary oxalosis in chronic renal insufficiency].
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Deutsch E
    Z Urol Nephrol; 1982 Jun; 75(6):409-14. PubMed ID: 7124142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between creatinine clearance and plasma homocysteine levels in predialytic chronic renal failure patients.
    Widiana IG; Suwitra K
    Acta Med Indones; 2004; 36(1):15-8. PubMed ID: 15931697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalic acid concentration in serum measured by isotopic clearance technique. Experience in hyper- and normo-oxaluric subjects.
    Prenen JA; Mees EJ; Boer P; Endeman HJ; Ephraim KH
    Proc Eur Dial Transplant Assoc; 1979; 16():566-70. PubMed ID: 549000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary hyperoxalemia caused by vitamin C supplementation in regular hemodialysis patients.
    Ono K
    Clin Nephrol; 1986 Nov; 26(5):239-43. PubMed ID: 3802587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma oxalate concentration in chronic renal disease.
    Boer P; van Leersum L; Hené RJ; Mees EJ
    Am J Kidney Dis; 1984 Sep; 4(2):118-22. PubMed ID: 6383028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.
    Kasidas GP; Rose GA
    Clin Chim Acta; 1986 Jan; 154(1):49-58. PubMed ID: 3943224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma oxalate in patients receiving continuous ambulatory peritoneal dialysis.
    Tomson CR; Channon SM; Parkinson IS; Owen JP; Ward MK; Simpson JM; Laker MF
    Nephrol Dial Transplant; 1988; 3(3):295-9. PubMed ID: 3140104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis.
    Mackensen-Haen S; Eissele R; Bohle A
    Lab Invest; 1988 Aug; 59(2):239-44. PubMed ID: 3404975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
    Caravaca F; Ruiz AB; Escola JM; Hernández Gallego R; Cerezo I; Fernández N; Barroso S; Martín MV
    Nefrologia; 2007; 27(4):466-71. PubMed ID: 17944584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Demography and effects of chronic renal insufficiency in Ile-de-France].
    Jungers P; Giraud E; Chauveau P; Geffriaud-Ricouard C; Man NK; Altman JJ; Jacobs C; Grünfeld JP
    Nephrologie; 1996; 17(8):429-34. PubMed ID: 9036365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology of severe chronic renal insufficiency in Burkina Faso].
    Lengani A; Coulibaly G; Laville M; Zech P
    Sante; 1997; 7(6):379-83. PubMed ID: 9503495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma adiponectin concentrations in patients with chronic renal failure: relationship with metabolic risk factors and ischemic heart disease.
    Tentolouris N; Doulgerakis D; Moyssakis I; Kyriaki D; Makrilakis K; Kosmadakis G; Stamatiadis D; Katsilambros N; Stathakis C
    Horm Metab Res; 2004 Oct; 36(10):721-7. PubMed ID: 15523599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of protein load on kidney functions in patients with chronic glomerulonephritis].
    Esaian AM; Kucher AG; Kaiukov IG; Ermakov IuA; Nikogosian IuA; Riabov SI
    Ter Arkh; 2002; 74(6):19-24. PubMed ID: 12136476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.